SARS CoV 2 News and Research

RSS

Henry Ford Health System first to enroll a pediatric patient in HEROS study

Henry Ford Health System is first in the country to enroll a patient in the Human Epidemiology and Response to SARS-CoV-2 study, which aims to help determine the rate of SARS-CoV-2, the virus that causes COVID-19, among U.S. children and their family members, and what percentage of children infected with SARS-CoV-2 develop symptoms of the disease.

20 May 2020

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

In a new study available on the preprint server bioRxiv, researchers demonstrate how the conformation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S-protein) can be controlled with the rational construct design, providing a framework for S-protein structure engineering in vaccine/drug development.

20 May 2020

African American communities more burdened by COVID-19, say researchers

A new study conducted by researchers at Florida International University, Miami, has found that communities in the United States with a high density of African Americans are disproportionately burdened with the adverse outcomes of coronavirus disease 2019 (COVID-19).

20 May 2020

Certain corticosteroid could improve severe COVID-19, say researchers

Researchers at Wayne State University and Henry Ford Health System in Michigan have conducted a study indicating that the corticosteroid methylprednisolone could improve outcomes among patients with severe coronavirus disease 2019 (COVID-19).

20 May 2020

Scientists use machine learning methods to estimate COVID-19's seasonal cycle

One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu - waning in warm summer months then resurging in the fall and winter.

20 May 2020

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. T

20 May 2020

New study initiated to establish the presence of SARS-CoV-2 in environmental samples

he Ministry of Science and Innovation, by way of the COVID-19 fund of the Carlos III Health Institute (ISCIII), is funding a study aimed at establishing the presence of SARS-CoV-2 in environmental samples as well as its indirect transmission potential.

20 May 2020

Immunologists propose possible molecular mechanism for the deadly respiratory syndrome

Research into how the SARS-CoV-2 virus induces death is suggesting potential treatments for its most destructive complications.

20 May 2020

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta Group plc has entered into an exclusive distribution agreement with Medusa19 Limited for sales of a saliva-based rapid test for the COVID-19 antigen.

From Avacta Life Sciences Ltd. 20 May 2020

Kids missing measles shots due to coronavirus pandemic

A year ago, the United States saw the highest annual number of measles cases since 1992, with 1,249 cases reported. Of these, 89 percent of the measles patients were unvaccinated or had an unknown vaccination status. Now, fears of another measles outbreak in the country loom as the coronavirus pandemic indirectly is causing a drop in measles vaccinations.

20 May 2020

Current antibody tests are good enough to inform decisions about public health, say experts

While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.

20 May 2020

CDC plans nationwide antibody study to determine the magnitude of the coronavirus pandemic

The U.S. Centers for Disease Control and Prevention (CDC) plans to launch a nationwide study to track how the novel coronavirus is spreading across the country.

20 May 2020

Moderna’s coronavirus vaccine candidate shows promise in phase I trial

Moderna, who partnered with the National Institutes of Health, announced that its candidate vaccine appeared to be safe when administered to eight healthy volunteers. The vaccine also stimulated an immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).

20 May 2020

Countries that develop a coronavirus vaccine may not share it, health expert warns

The pandemic has sparked a worldwide race to develop a vaccine against the novel coronavirus. But a health expert has warned that the world might face a risk of "vaccine nationalism," wherein countries who will produce a coronavirus vaccine will not share it with others.

20 May 2020

Mount Sinai venture to develop and scale distribution of COVID antibody test kits

Mount Sinai Health System ("Mount Sinai") and Renalytix AI today announced the formation of Kantaro Biosciences, LLC ("Kantaro"), a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies.

20 May 2020

Methodologies to detect the presence of SARS-CoV-2

In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.

20 May 2020

Ortho receives CE mark for COVID-19 IgG antibody test

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its second COVID-19 antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test received CE Mark. The test offers 100% specificity.

From Ortho-Clinical Diagnostics, Inc. 20 May 2020

New drug treatment can reduce risk of death from COVID-19 infection

Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could--if given early enough--potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.

20 May 2020

Australian COVID-19 prevention trial begins for frontline and allied healthcare workers

COVID SHIELD is a major collaborative effort led by the Walter and Eliza Hall Institute of Medical Research in partnership with human data science company IQVIA.

19 May 2020

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Treatment with antibodies purified from donated blood - immune globulin therapy - and steroids restored heart function in the majority of children with COVID-related multi-system inflammatory syndrome, according to new research published yesterday in Circulation, the flagship journal of the American Heart Association.

19 May 2020

SARS CoV 2 News and Research

Henry Ford Health System first to enroll a pediatric patient in HEROS study

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

African American communities more burdened by COVID-19, say researchers

Certain corticosteroid could improve severe COVID-19, say researchers

Scientists use machine learning methods to estimate COVID-19's seasonal cycle

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

New study initiated to establish the presence of SARS-CoV-2 in environmental samples

Immunologists propose possible molecular mechanism for the deadly respiratory syndrome

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Kids missing measles shots due to coronavirus pandemic

Current antibody tests are good enough to inform decisions about public health, say experts

CDC plans nationwide antibody study to determine the magnitude of the coronavirus pandemic

Moderna’s coronavirus vaccine candidate shows promise in phase I trial

Countries that develop a coronavirus vaccine may not share it, health expert warns

Mount Sinai venture to develop and scale distribution of COVID antibody test kits

Methodologies to detect the presence of SARS-CoV-2

Ortho receives CE mark for COVID-19 IgG antibody test

New drug treatment can reduce risk of death from COVID-19 infection

Australian COVID-19 prevention trial begins for frontline and allied healthcare workers

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News